Capac Biotechnologies: Shareholder Yunnan Zhonghe intends to reduce its stake by no more than 3%.

Cap Bio announced that Yunnan Zhonghe Enterprise Management Co., Ltd., a shareholder holding more than 5% of the shares, plans to reduce its shareholding by no more than 19.395 million shares, or 3% of the total share capital of the company, within 3 months after 15 trading days from the date of the announcement through centralized bidding or block trading. The reason for the reduction is for its own fund needs, and the shares are from the shares held before the company's initial public offering and the capital reserves converted into shares.